Related references
Note: Only part of the references are listed.Circulating low density neutrophils of breast cancer patients are associated with their worse prognosis due to the impairment of T cell responses
Diana P. Saraiva et al.
Oncotarget (2021)
Neutrophil elastase selectively kills cancer cells and attenuates tumorigenesis
Chang Cui et al.
CELL (2021)
Tumor-Derived Factors Differentially Affect the Recruitment and Plasticity of Neutrophils
Ludovica Arpinati et al.
CANCERS (2021)
Tumor-Associated Neutrophils Drive B-cell Recruitment and Their Differentiation to Plasma Cells
Merav E. Shaul et al.
CANCER IMMUNOLOGY RESEARCH (2021)
PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy
Jinhua Liu et al.
FRONTIERS IN PHARMACOLOGY (2021)
The PD-L1/PD-1 Axis Blocks Neutrophil Cytotoxicity in Cancer
Olga Yajuk et al.
CELLS (2021)
NETosis in cancer: a critical analysis of the impact of cancer on neutrophil extracellular trap (NET) release in lung cancer patients vs. mice
Ludovica Arpinati et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
Circulating neutrophil subsets in advanced lung cancer patients exhibit unique immune signature and relate to prognosis
Merav E. Shaul et al.
FASEB JOURNAL (2020)
Synergic effect of PD-1 blockade and endostar on the PI3K/AKT/mTOR-mediated autophagy and angiogenesis in Lewis lung carcinoma mouse model
Jing Wu et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
The role of granulocyte colony-stimulating factor in breast cancer development: A review
Li Liu et al.
MOLECULAR MEDICINE REPORTS (2020)
Neutrophil depletion enhances the therapeutic effect of PD-1 antibody on glioma
Peng-Fei Wang et al.
Aging-US (2020)
Polymorphonuclear myeloid-derived suppressor cells limit antigen cross- presentation by dendritic cells in cancer
Alessio Ugolini et al.
JCI INSIGHT (2020)
Atezolizumab for First-Line Treatment of PD-L1-Selected Patients with NSCLC
Roy S. Herbst et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Tumor-associated neutrophils suppress antitumor immunity of NK cells through the PD-L1/PD-1 axis
Rui Sun et al.
TRANSLATIONAL ONCOLOGY (2020)
G-CSF and G-CSFR Modulate CD4 and CD8 T Cell Responses to Promote Colon Tumor Growth and Are Potential Therapeutic Targets
Ioannis Karagiannidis et al.
FRONTIERS IN IMMUNOLOGY (2020)
Advanced G-CSF-producing non-small cell lung cancer-not otherwise specified, with favourable response to pembrolizumab monotherapy
Yohei Matsui et al.
RESPIROLOGY CASE REPORTS (2020)
Farnesoid X Receptor Constructs an Immunosuppressive Microenvironment and Sensitizes FXRhighPD-L1low NSCLC to Anti-PD-1 Immunotherapy
Wenjie You et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Tumour-associated neutrophils in patients with cancer
Merav E. Shaul et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Reactive Oxygen Species in the Tumor Microenvironment: An Overview
Frank Weinberg et al.
CANCERS (2019)
The neutrophil: one cell on many missions or many cells with different agendas?
Gustaf Christoffersson et al.
CELL AND TISSUE RESEARCH (2018)
Neutrophil phenotypes in health and disease
Pien Hellebrekers et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2018)
Neutrophil elastase in the tumor microenvironment
Irina Lerman et al.
STEROIDS (2018)
Change in neutrophil-to-lymphocyte ratio (NLR) in response to immune checkpoint blockade for metastatic renal cell carcinoma
Aly-Khan A. Lalani et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Sanjeev Mariathasan et al.
NATURE (2018)
Tumour-activated neutrophils in gastric cancer foster immune suppression and disease progression through GM-CSF-PD-L1 pathway
Ting-ting Wang et al.
GUT (2017)
Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab
Stefan Diem et al.
LUNG CANCER (2017)
Neutrophils and Snail Orchestrate the Establishment of a Pro-tumor Microenvironment in Lung Cancer
Julien Faget et al.
CELL REPORTS (2017)
Dynamics of Neutrophils-to-Lymphocyte Ratio Predict Outcomes of PD-1/PD-L1 Blockade
Michele Moschetta et al.
BIOMED RESEARCH INTERNATIONAL (2017)
Blockade of only TGF-β 1 and 2 is sufficient to enhance the efficacy of vaccine and PD-1 checkpoint blockade immunotherapy
Masaki Terabe et al.
ONCOIMMUNOLOGY (2017)
Precision medicine in immune checkpoint blockade therapy for non-small cell lung cancer
Xiaoming Liu et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2017)
High neutrophil to lymphocyte ratio measured before starting ipilimumab treatment is associated with reduced overall survival in patients with melanoma
J. Zaragoza et al.
BRITISH JOURNAL OF DERMATOLOGY (2016)
Type I IFNs induce anti-tumor polarization of tumor associated neutrophils in mice and human
Lisa Andzinski et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
PD-1/PD-L1 blockade in cancer treatment: perspectives and issues
Junzo Hamanishi et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2016)
Neutrophil myeloperoxidase and its substrates: formation of specific markers and reactive compounds during inflammation
Yoji Kato
JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION (2016)
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer
Martin Reck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Human neutrophils: Their role in cancer and relation to myeloid-derived suppressor cells
Katrin Moses et al.
SEMINARS IN IMMUNOLOGY (2016)
G-CSF is a key modulator of MDSC and could be a potential therapeutic target in colitis-associated colorectal cancers
Wenbin Li et al.
PROTEIN & CELL (2016)
Tumor-associated neutrophils display a distinct N1 profile following TGFβ modulation: A transcriptomics analysis of pro- vs. antitumor TANs
Merav E. Shaul et al.
ONCOIMMUNOLOGY (2016)
Prognostic significance of neutrophil-to-lymphocyte ratio in prostate cancer: evidence from 16,266 patients
Xiaobin Gu et al.
SCIENTIFIC REPORTS (2016)
Neutrophils in cancer: neutral no more
Seth B. Coffelt et al.
NATURE REVIEWS CANCER (2016)
Peritumoural neutrophils negatively regulate adaptive immunity via the PD-L1/PD-1 signalling pathway in hepatocellular carcinoma
Gaixia He et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)
Distinct Functions of Neutrophil in Cancer and Its Regulation
Zvi Granot et al.
MEDIATORS OF INFLAMMATION (2015)
The prognostic landscape of genes and infiltrating immune cells across human cancers
Andrew J. Gentles et al.
NATURE MEDICINE (2015)
Phenotypic Diversity and Plasticity in Circulating Neutrophil Subpopulations in Cancer
Jitka Y. Sagiv et al.
CELL REPORTS (2015)
Neutrophils in Cancer: Two Sides of the Same Coin
Eileen Uribe-Querol et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2015)
Tumor-Associated Neutrophils as a New Prognostic Factor in Cancer: A Systematic Review and Meta-Analysis
Meixiao Shen et al.
PLOS ONE (2014)
Tumor-associated neutrophils (TAN) develop pro-tumorigenic properties during tumor progression
Inbal Mishalian et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Neutrophil recruitment and function in health and inflammation
Elzbieta Kolaczkowska et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Tumor Entrained Neutrophils Inhibit Seeding in the Premetastatic Lung
Zvi Granot et al.
CANCER CELL (2011)
Myeloid-derived suppressor cells in the peripheral blood of cancer patients contain a subset of immature neutrophils with impaired migratory properties
Sven Brandau et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2011)
Tumor-Derived G-CSF Facilitates Neoplastic Growth through a Granulocytic Myeloid-Derived Suppressor Cell-Dependent Mechanism
Jeremy D. Waight et al.
PLOS ONE (2011)
Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: N1 versus N2 TAN
Zvi G. Fridlender et al.
CANCER CELL (2009)
First and subsequent cycle use of pegfilgrastim prevents febrile neutropenia in patients with breast cancer: A multicenter, double-blind, placebo-controlled phase III study
CL Vogel et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Share Paper
